In early 2024, a single incorrect answer from a flagship AI chatbot wiped $100 billion from a tech giant’s market value in hours. Around the same time, an airline’s chatbot was forced by a court to honor a refund policy it completely invented. These aren’t isolated glitches; they are symptoms of a deep and dangerous […]
The $100 Billion Mistake: Is Your AI a Ticking Time Bomb? Read More »
The Silent Crisis in Biotech Finance: How Blockchain Fixes CRO Accounting Challenges The Silent Crisis in Biotech Finance: How Blockchain Fixes CRO Accounting Challenges Leading biotech organizations are pushing boundaries in therapeutic innovation, advancing cell therapies, rare disease interventions, and precision medicine. AI-powered drug discovery platforms are identifying viable targets faster than ever before. Adaptive
In 2025, the most significant opportunity in institutional finance isn’t a new algorithm or trading strategy. It’s an infrastructure upgrade. Boston Consulting Group projects that the market for tokenized illiquid assets will reach $16 trillion by 2030. This isn’t just a trend; it’s a fundamental re-plumbing of capital markets. For decades, the highest-value real-world assets
Biotech is no stranger to innovation—it’s built into its DNA. Today, the industry stands at a transformative crossroads: AI is accelerating drug discovery pipelines, decentralized trials are reshaping patient access, and gene therapies are redefining what personalized medicine can achieve. In a field driven by molecules, models, and milestone approvals, the pace of progress has
Biotech’s Blind Spot: Why Verifiable Data Integrity Is Now a Strategic Imperative Read More »
FLEXBLOK is a Blockchain-as-a-Service (BaaS) platform that simplifies blockchain adoption by enabling fast, cost-effective development of blockchain applications.
A Innoflexion Initiative
www.innoflexion.com
Get the latest industry insights, product updates, and exclusive offers delivered straight to your inbox..